Adamis Pharmaceuticals recalls
Adamis Pharmaceuticals has 2 recalls on record with the FDA and USDA, the earliest in 2022 and the latest reported on 13 Apr 2022.
Total recalls2since 2022
Last 12 months0reported
Class I2100% of total
Ongoing0latest 13 Apr 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 2 100%Class II 0 0%Class III 0 0%
Why adamis pharmaceuticals is recalled
Product types
By year
All adamis pharmaceuticals recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Symjepi (epinephrine injection, USP) 3 mg, 3 mg recalled | Adamis Pharmaceuticals | Other | Nationwide |
| Drug | CLASS I | Symjepi (epinephrine injection, USP) 15 mg 15 mg recalled | Adamis Pharmaceuticals | Other | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.